This article is more than 5 years old. Information may no longer be current.

Roche recalls insulin infusion set

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Roche Insulin Delivery Systems has recalled the Accu-Chek FlexLink Plus insulin infusion set because of the potential for underdelivery of insulin.

The product may have a kinked or bent cannula when inserting the infusion set, leading to insufficient insulin delivery and potential hyperglycemia.

The recall applies only to the Accu-Chek FlexLink Plus infusion set that was launched in November 2010, according to an FDA release. Use of the previous version of Accu-Chek Ultraflex or other Accu-Chek infusion sets or insulin pumps are not affected by the recall.

Patients and health care professionals are encouraged to discontinue use of any Accu-Chek FlexLink Plus infusion sets, and professionals should discuss changes to therapy with patients.

Roche customer care can provide support for obtaining alternative infusion sets. Until this issue is fixed, the Accu-Chek FlexLink Plus infusion sets will not be available.